title: [Flu vaccine in children: state of the art].
abstract: Influenza is an acute respiratory illness that year to year causes considerable morbidity and mortality. . All children, healthy or at high risk, are susceptible to this infection. Influenza vaccine seems to be effective in preventing influenza-like illness, laboratory-confirmed infection, and hospitalizations and deaths, demonstrating cost-effectiveness. Inactivated and live-attenuated vaccines have a similar efficacy profile. . Due to high influenza associated hospitalization rates in children, some countries have recommended incorporating influenza vaccination into the universal immunization program for healthy infants between 6-24 months of age. Considering that this public-health policy has been incorporated in Chile, local studies assessing its impact are needed.
authors.affiliation: Departamento de Pediatría, Hospital Clínico Pontificia Universidad Católica de Chile, Chile. levega@puc.cl
authors.forename: Luis E
authors.initials: LE
authors.lastname: Vega-Briceño
authors.forename: Katia
authors.initials: K
authors.lastname: Abarca V
authors.forename: Ignacio
authors.initials: I
authors.lastname: Sánchez D
mesh_terms: D002648:Child; D002675:Child, Preschool; D002677:Chile / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D006801:Humans; D017589:Immunization Programs / Q000379:methods*; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D007252:Influenza Vaccines